Artemisinin resistance in Plasmodium falciparum

The Lancet Infectious Diseases

Volumn 14, Issue 6, 2014, Pages 449-450

  Amaratunga, Chanaki ^a   Witkowski, Benoit ^b   Khim, Nimol ^b   Menard, Didier ^b   Fairhurst, Rick M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; K 13;

ALLELE; ANTIBIOTIC RESISTANCE; GENOTYPE; HUMAN; LETTER; MALARIA; PARASITE CLEARANCE; PARASITE SURVIVAL; PHASE 1 CLINICAL TRIAL (TOPIC); PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SURVIVAL RATE;

ANTIMALARIALS; ARTEMISININS; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84900838464     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70777-7     Document Type: Letter

References (3)

1. Witkowski B, Amaratunga C, Khim N, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis 2013, 13:1043-1049.
2. Lopera-Mesa TM, Doumbia S, Chiang S, et al. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity. J Infect Dis 2013, 207:1655-1663.
3. Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2014, 505:50-55.